PTEN was discovered to be the target of multiple miRNAs, such as miR-21, which is overexpressed in triple negative and HER2+ (human epidermal growth factor receptor 2-positive) BCs, leading to the advancement of the tumor (Figure 3) (23). This evidence concerns the gene ERBB2 and neoplasm.